Nestec S.a.

L'oreal

Societe Des Produits Nestle S.a.

Beth Israel Deaconess Medical Center, Inc.

Fabiola Dionisi

Frederic Destaillats

Cristina Cruz-Hernandez

Julie Moulin

Isabelle Masserey-Elmelegy

Manuel Oliveira

Bruce R Bistrian

Marjorie Guitard

Rachid Bel Rhlid

Angus Moodycliffe

Christoph Thomas Reh

Lennart Fries

Annick Mercenier

Sebastien Holvoet

Laurent Sagalowicz

Zeynel Deniz Gunes

Christina Vafeiadi

Lucas Actis Goretta

Christian Kjolby

Gary Williamson

Anurag Singh

Sanyasi Gaddipati

Magalie Sabatier

Laure Poquet

Isabel Fernandez Farres

Cyril Moccand

Joydeep Ray

Karin Kraehenbuehl

Maarit Rein

Marcia Da Silva Pinto

Antoine Leveques

Patricia Rossi

Frédéric Destaillats

Jean-Luc Sauvageat

Marianne Studer

Patricia Rossi Vauthey

Mathieu Renouf

Sébastien Holvoet

Julie Céline Moulin

Olivier Mauroux

The present invention relates to a composition comprising a dispersion of dietary fibre particles in fat. In particular, a composition wherein the dietary fibre particles comprise water. Further aspects of the invention include the use of the composition to reduce saturated fatty acid content, a process for preparing the composition and a food product.

Dietary fibre composition

The present invention relates to a process for forming a stabilized fat blend. Further aspects of the invention are a composition comprising a fat blend and micronized antioxidant-containing vegetable material. The invention also provides for the use of micronized antioxidant-containing vegetable material to protect a fat blend from oxidation, for example a fat blend with a low level of saturated fat.

Stabilized fat blend

The present invention relates generally to the field of flavan-3-ols. In particular, the present invention provides a way to increase the bioavailability of flavan-3-ols. Embodiments of the present invention relate to the use of at least one polyphenolic compound in a composition comprising at least one flavan-3-ol for increasing the bioavailability of said flavan-3-ol, wherein the at least one polyphenolic compound is selected from a group consisting of flavonols, flavones, isoflavones, flavanones, or combinations thereof.

Increasing the bioavailability of flavan-3-ols by polyphenols

The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising a sn-2 monoacylglycerol derivative, wherein the sn-1 and sn-3 positions are blocked by protective groups. The acyl group may be a fatty acid, for example one with anti-inflammatory properties.

Sn-2-monoacylglycerols and lipid malabsorption

The present invention relates to epicatechin for use in the prevention or reduction of symptoms of an allergic disorder and/or an allergic reaction. The invention further relates to epicatechin for said use in the form of food, food product, food supplement or pharmaceutical products.

Epicatechin for alleviating symptoms of allergy

Sn-2-monoacylgycerols and lipid malabsorption

The present invention relates generally to the field of food supplements and/or food products for cosmetic purpose. More specifically, the present invention aims to provide an ingredient containing caftaric acid and/or derivatives for preventing and/or treating hyper-pigmentation of skin, skin color imperfections such as age-spots and other skin disorders characterized by abnormal pigments. The present invention also aims at improving skin tone as well as providing a skin lightening agent.

Use of caftaric acid and derivatives in food supplement for regulating skin pigmentation

The present invention relates generally to the field of cosmetic and/or food supplement. More specifically, the present invention aims to provide the use of at least an ingredient containing caftaric acid and/or derivatives and a micro-organism and/or an enzyme capable of hydrolyzing caftaric acid and/or derivatives thereof to generate tartaric and/or caffeic acid, for improving skin tone and preventing and/or treating hyper-pigmentation of skin and/or skin color imperfections such as age-spots and other skin disorders characterized by abnormal pigments. Also, the present invention aims at providing a skin lightening agent.

Use of caftaric acid and lactic bacterium in food supplement for regulating skin pigmentation

The present invention relates generally to the field of food supplements for cosmetic purpose. More specifically, the present invention aims to provide an ingredient containing chicoric acid and/or derivatives for preventing and/or treating hyper-pigmentation of skin, skin color imperfections such as age-spots and other skin disorders characterized by abnormal pigments. The present invention also aims at improving skin tone as well as providing a skin lightening agent.

Use of chicoric acid and derivatives for regulating skin pigmentation

The present invention relates generally to the field of cosmetic and/or food supplement. More specifically, the present invention aims to provide the use of at least an ingredient containing chicoric acid and/or derivatives and a micro-organism and/or an enzyme capable of hydrolyzing chicoric acid and/or derivatives thereof to generate tartaric and/or caffeic acid, for improving skin tone and preventing and/or treating hyper-pigmentation of skin and/or skin color imperfections such as age-spots and other skin disorders characterized by abnormal pigments. Also, the present invention aims at providing a skin lightening agent.

Use of chicoric acid and lactic bacterium in food supplement for regulating skin pigmentation

The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising sn-1(3) monoacylglycerols, wherein the sn-1 or sn-3 position is occupied by an acyl group such as a fatty acid and the sn-2 position remains unoccupied. The fatty acid may be one with anti-inflammatory properties.

Sn-1(3) monoacylglycerides and lipid absorption

Growing community of inventors

Epalinges, Switzerland

Fabiola Dionisi